Member Info for gggg21

Actually stephen even initiates talking about it being used in this way in care homes, just watched it again.

https://t.co/WNrQYSPt7G?amp=1

This was posted on twitter earlier as a reminder, go to around 7mins 40....care homes specifically mentioned and about using it protect...it does line up with this again. https://www.gov.uk/government/news/trials-to-find-preventative-covid-19-treatments-for-most-vulnerable-to-launch-in-uk

http://nnoc.info/march-26-us-cuba-collaboration-resolution-passed-by-minneapolis-city-council/

Looks like things will be getting a lot more interesting, this is from late Friday. The US acknowledging and working with Cuba saying how impressed they are with their response to covid and wanting to learn......Cuba the biggest advocates of interferon....US trial with an interferon product on....SNG

I don’t know what worry is. Phase 2 results were outstanding. They have data from HT trial and we saw Friday that they have decided to join bia...if you had bad results you would be wanting to keep quiet, clearly they are not. The activ2 trial continues (US cases up 12% on weekly sadly so that will be accelerating and easy to fill that trial space) phase 3 continues. I can think of 7 rns that could be expected any day now and certainly in April 1) HT prelim read our 2) partnership/jv 3) tr1 4) activ-2 Numbers filled 5) prelim results with overall update on numbers completed in trial 6) HT overall results 7) agreement with a government

And the whole time the drum for interferon gets louder. Basically reiteration of how targeted interferon can help against covid. https://amp.redaccionmedica.com/secciones/sanidad-hoy/covid-grave-hombres-jovenes-causa-genetica-1970?__twitter_impression=true

There’s that element but you also get the element that on Monday it is 46 days minimum since dosing in activ-2 and then within 4 trading days that suddenly becomes 54 trading days. So could it be fomo time this week with so many possible rns that could be big moves.

So 4 trading days time then as market is closed Friday and Monday. Ages to drift eh

The U.K. government never want to mention novacyt but they are the most in bed diagnostic company in the U.K. now and had the highest spend with the U.K. goverment.....

Not putting values on it. But put values on reducing s evere COVID by 79% read that rns etc. What if the earlier inception of disease is even better. The cost of lockdown in U.K. alone has been over 250bn. Ok vaccines will help along with other drugs etc. But then say you have a therapeutic for respiratory disease for foreseeable. Current mcap would be far far to cheap. You can sit back and relax and watch the scramble to get in. Numis broker note was £10 for a reason. I always say take 20% off broker notes

Forgot about that cr1909. I’m intrigued as to what is going on behind closed doors again. I know they have had the initial phase 2 ht data for two weeks this week coming. Visibility will surely be high. Wouldn’t it be another great U.K. pr achievement that they have another early potential therapeutic to prevent hospitalisation and this strain on nhs allowing U.K. to continue its path back to normal.....let’s wait and see

It’s going to be interesting. Synairgen is a U.K. company. US made the big move putting synairgen on activ2 with potential fast track to fda eua and American claiming the win....synairgen is a U.K. company....waiting for the U.K. move now.....tick tock (remember the current goverment slogans and move “british leading etc etc etc etc”. Bia seemed interesting as it seemed a nod back to the U.K. tug of war anyone.

Pfizer vaccines everyone believes is US and the first....it’s actually biontech German.

My bad on the interferon element I was trying to remember the article with investor. Yes we would get to vote on it. All good points. I think there are some major pharmas that’s it on Activ2 bird anyway so they would get views. This is why I think people saying HT is not that big of deal are wrong....it is as it’s basically identical to what activ2 is so if it reports positivity then it becomes completely derisked investment. All imo anyway have a good evening all.

Oakleaf in a way as a listed company they would have no real choice if a takeover offer came in or even jv. They got to do what is best for shareholders and with some large funds like polar it would be out of their hands. They would have to report the info to us shareholders and we would vote on it. Whether some of the team stay on etc. Who knows. The most obvious for me would be thermofisher as they produce the interferon for us already, they are on the expansion trail both organically and through acquisition. They have a large cash pot due to covid diagnostics sales, very in bed with the US government and worldwide global reach. Would make perfect sense. AZ obviously may have something to say about all this as they were very close a few years back. Figure back then was around 200m so with current environmental you could possibly add a 0 on to that. Just my thoughts anyway as I can not believe some discussions would not have already have been took place. More positive HT data will make this even more likely as it is basically what the activ2 trial is so you would then be very confident of it being pushed to the next stage of activ2 final trial. Exciting times ahead.

What are the odds of a mou with exclusivity agreement to commercialising sng if successful in phase 3. These conversations imo must be going on currently to gain first mover advantage.

Interestingly channel 5 journos liking synairgen posts on twitter. No previous interaction with synairgen or that so wonder what the sudden interest is from them seems like they hunted synairgen out. Maybe a news article coming out soon or maybe just casual coincidence but they clearly looked for it.

It’s all adding up. I do not know of a more promising potential therapeutic against not only covid but respiratory disease. Phase 3 trial and on activ2 what is not to like big few months to come https://www.frontiersin.org/articles/10.3389/fimmu.2021.655528/full

Anything to do with this? I mean you don’t join a trade association if you have nothing to sell https://www.bioindustry.org/news-listing/bia-welcomes-1bn-investment-deal-and-launch-of-life-sciences-investment-programme.html

Why would they be joining a trade association
https://mobile.twitter.com/BIA_UK/status/1375462554076467210

I think its amazing you have "investors" who "hold" shares but have no faith in the company, the therapeutic, the market or the ceo. Heard all this nonsense from similar accounts prior to US news...Amazing how sng got on the Activ2 trial look at the names on it. But hey its all going to tank bla bla bla

"This one's to buy and hold with sticky hands..." In out in out shake it all about